cervical%20cancer%20-%20prevention%20-and-%20screening
CERVICAL CANCER - PREVENTION & SCREENING
Mortality due to cervical cancer can be reduced by prevention, early detection & treatment.
Vaccination may be started as early as 9 years old.
Vaccination may reduce the incidence of HPV-related disease.
Screening for cervical cancer after vaccination is still recommended because only 70% of the virus types associated w/ invasive cervical cancer consist of HPV 16 & 18 types & women may not be entirely protected if they have been infected w/ other HPV types prior to vaccination.

Introduction

Routine Vaccination

  • Females, 11-12 years of age, are recommended to receive 2 doses of human papilloma virus (HPV) vaccine 6-12 months apart
    • Vaccination may be started as early as 9 years old
  • World Health Organization (WHO) recommends a 2-dose vaccination schedule with a minimum interval of 6 months between doses for females <15 years old
    • For females ≥15 years old and immunocompromised individuals, the 3-dose vaccination schedule is recommended

Catch-Up Dose

  • Females, 13-26 years of age, who have not been previously vaccinated or those who have not completed the doses
    • Those who have not received any previous HPV vaccination should receive a 3-dose vaccine series  
    • Those who have received 2 doses of HPV vaccine at least 5 months apart before the age of 15 years are adequately vaccinated and do not need any additional HPV vaccine dose
    • Those who have received only 1 dose or 2 doses <5 months apart before the age of 15 years are not adequately vaccinated and must receive an additional HPV vaccine dose 
  • HPV exposure risks should be discussed with females 18-45 years old
    • Vaccination would provide full benefit to sexually active females who have not been infected by HPV
    • Less benefit is provided to sexually active females who have been infected by one or more HPV types
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Vincent YT Cheung, 01 Dec 2015

Ultrasonography has been widely used as a routine component of antenatal care. During the assessment of the foetus and the placenta, an adnexal mass may be discovered at the time of the ultrasound examination. Occasionally, an adnexal mass can also be suspected either on physical examination or as a result of clinical symptoms.
26 Feb 2017
Placement of cervical pessary in women with short cervices and singleton pregnancies does not lower the risk of having preterm births, according to the results of a meta-analysis.
Asykin Ismail, Dr. Jazlan Joosoph, 17 Mar 2018
Obstetrician and gynaecologist at Raffles Hospital, Dr Jazlan Joosoph, shares the lowdown on the condition, diagnosis and treatment options.
Roshini Claire Anthony, 07 Sep 2016

Estrogen receptor α (ESR1) mutations Y537S and D538G are associated with reduced overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer, according to findings of a secondary analysis of the BOLERO-2* clinical trial.